Harpel P C, Gordon B R, Parker T S
Department of Medicine, New York Hospital-Cornell Medical Center, NY 10021.
Proc Natl Acad Sci U S A. 1989 May;86(10):3847-51. doi: 10.1073/pnas.86.10.3847.
Lipoprotein (a) [Lp(a)] is a plasma component whose concentration is related to the development of atherosclerosis, although the underlying mechanisms are not known. Lp(a) contains a unique structure, apolipoprotein (a), that shares partial homology with plasminogen. We now report that plasmin catalyzes the binding of Lp(a) to both immobilized fibrinogen and fibrin in a manner analogous to our previously reported studies with plasminogen. Plasmin treatment of immobilized fibrinogen induces a 3.7-fold increase in Lp(a) binding. Low density lipoprotein, molecules similar to Lp(a) but lacking apolipoprotein (a), bind poorly to immobilized fibrinogen and binding is not increased by plasmin. Trypsin but not neutrophil elastase also increases the binding of Lp(a) to fibrinogen. Lp(a) also complexes to plasmin-fibrinogen digests, and binding increases in proportion to the time of plasmin-induced fibrinogen degradation. Lp(a) binding is lysine-binding site dependent as it is inhibited by epsilon-aminocaproic acid. Lp(a) inhibits the binding of plasminogen to plasmin-modified immobilized fibrinogen, indicating that both molecules compete for similar lysine-binding sites. These findings demonstrate an affinity between Lp(a) and protease-modified fibrinogen or fibrin and thereby provide a potential mechanism to explain the association between thrombosis, coronary atherosclerosis, and increased blood concentrations of Lp(a).
脂蛋白(a)[Lp(a)]是一种血浆成分,其浓度与动脉粥样硬化的发展有关,尽管其潜在机制尚不清楚。Lp(a)含有一种独特的结构,即载脂蛋白(a),它与纤溶酶原具有部分同源性。我们现在报告,纤溶酶催化Lp(a)与固定化纤维蛋白原和纤维蛋白的结合,其方式类似于我们之前报道的关于纤溶酶原的研究。用纤溶酶处理固定化纤维蛋白原可使Lp(a)的结合增加3.7倍。低密度脂蛋白,分子与Lp(a)相似但缺乏载脂蛋白(a),与固定化纤维蛋白原结合较差,且纤溶酶不会增加其结合。胰蛋白酶而非中性粒细胞弹性蛋白酶也能增加Lp(a)与纤维蛋白原的结合。Lp(a)还能与纤溶酶-纤维蛋白原消化产物形成复合物,且结合量与纤溶酶诱导的纤维蛋白原降解时间成正比。Lp(a)的结合依赖于赖氨酸结合位点,因为它会被ε-氨基己酸抑制。Lp(a)抑制纤溶酶原与纤溶酶修饰的固定化纤维蛋白原的结合,表明这两种分子竞争相似的赖氨酸结合位点。这些发现证明了Lp(a)与蛋白酶修饰的纤维蛋白原或纤维蛋白之间存在亲和力,从而提供了一种潜在机制来解释血栓形成、冠状动脉粥样硬化与Lp(a)血液浓度升高之间的关联。